Big Data in Stroke: How to Use Big Data to Make the Next Management Decision

Neurotherapeutics. 2023 Apr;20(3):744-757. doi: 10.1007/s13311-023-01358-4. Epub 2023 Mar 10.

Abstract

The last decade has seen significant advances in the accumulation of medical data, the computational techniques to analyze that data, and corresponding improvements in management. Interventions such as thrombolytics and mechanical thrombectomy improve patient outcomes after stroke in selected patients; however, significant gaps remain in our ability to select patients, predict complications, and understand outcomes. Big data and the computational methods needed to analyze it can address these gaps. For example, automated analysis of neuroimaging to estimate the volume of brain tissue that is ischemic and salvageable can help triage patients for acute interventions. Data-intensive computational techniques can perform complex risk calculations that are too cumbersome to be completed by humans, resulting in more accurate and timely prediction of which patients require increased vigilance for adverse events such as treatment complications. To handle the accumulation of complex medical data, a variety of advanced computational techniques referred to as machine learning and artificial intelligence now routinely complement traditional statistical inference. In this narrative review, we explore data-intensive techniques in stroke research, how it has informed the management of stroke patients, and how current work could shape clinical practice in the future.

Keywords: Artificial intelligence; Big data; Deep learning; Machine learning; Stroke complications; Stroke management.

Publication types

  • Review

MeSH terms

  • Artificial Intelligence*
  • Big Data
  • Fibrinolytic Agents
  • Humans
  • Machine Learning
  • Stroke* / etiology
  • Stroke* / therapy

Substances

  • Fibrinolytic Agents